EMEA-000420-PIP01-10

Key facts

Invented name
  • Ariclaim
  • Yentreve
  • Xeristar
  • Cymbalta
Active substance
duloxetine hydrochloride
Therapeutic area
Uro-nephrology
Decision number
P/268/2010
PIP number
EMEA-000420-PIP01-10
Pharmaceutical form(s)
  • Gastro resistant capsule
  • Capsule (hard)
Condition(s) / indication(s)
  • Treatment of chronic pain
  • Treatment of diabetic neuropathic pain
  • Treatment of generalised anxiety disorder
  • Treatment of major depressive disorder
  • Treatment of stress urinary incontinence
Route(s) of administration
Oral use
Contact for public enquiries
Eli Lilly & Company
eu_paediatric@lilly.com
United Kingdom
Phone: +44 01276483000
Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating